Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
D000661:Amphetamine / Q000378:metabolism; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D003913:Dextroamphetamine / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects*; D007583:Jejunum / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014439:Tyramine / Q000037:antagonists & inhibitors / Q000378:metabolism
D001679:Biogenic Amines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D010293:Pargyline; D000661:Amphetamine; D005947:Glucose; D003913:Dextroamphetamine; D014439:Tyramine